The Hidden Cost of Fragmented Weight Management Benefits
You’re already spending on weight management. The GLP-1 prescriptions are going through. The bariatric surgery benefit is in the plan. Maybe you’ve even added a nutrition coaching app. On paper, you’ve checked the boxes.
So why are your obesity-related costs still climbing?
The answer, for most self-insured employers, isn’t that you’re spending too little. It’s that the dollars you’re already spending aren’t connected to each other—and that gap is costing you more than the conditions themselves. This is the fragmented benefits problem. And in 2026, it’s the most expensive line item most employers haven’t named yet.
What “fragmented” actually means in weight management
Fragmentation in employee benefits isn’t new. But it’s become especially damaging in weight management, because effective obesity treatment requires a sequence of interventions—not a single one.
A member’s weight management journey might start with GLP-1 medication through their pharmacy benefit. They lose weight initially, but without nutrition support, they struggle with side effects and stop the medication. They regain the weight. A year later, their BMI has climbed enough to qualify for bariatric surgery, which is covered under a completely different benefit, administered by a different vendor, with no record of the prior medication history. Post-surgery, they experience anxiety and depression, which are common in bariatric patients, but the behavioral health benefit is a third vendor with no visibility into the surgical care episode.
At no point did these three interventions talk to each other. At no point did any vendor flag the member for a different pathway when one wasn’t working. And at every transition, the employer paid again—for a new intake, a new care navigator, and often a worse outcome.
That is what fragmentation looks like in practice. And it’s the rule, not the exception, in how most employer benefits stacks are designed today.
The numbers behind the problem
The financial stakes are significant. More than 40% of adults in the U.S. struggle with obesity, and in 2023, obesity cost U.S. businesses approximately $425.5 billion—$146.5 billion in excess medical costs and $243 billion in lost workplace productivity.
On an individual level, the math is striking:
Employees with obesity or overweight diagnoses incur an average of $12,588 in annual health costs—more than double the $4,699 average for employees without those diagnoses.
That delta is what employers are trying to close. The problem is that the solutions they’re deploying aren’t designed to work together—and when benefits are fragmented, each intervention underperforms.
The GLP-1 cost spiral
GLP-1 medications have transformed how employers think about weight management. They work. The results are real. But the way most employers are covering them is unsustainable.
From 2018 to 2023, employer spending on GLP-1s rose by more than 500%. GLP-1s now account for more than 10% of total annual insurance claims for many employers. The average annual list price of a GLP-1 is $12,000—roughly $1,000 per member per month—and that number doesn’t include the cost of managing side effects, monitoring metabolic markers, or supporting members through the lifestyle changes that determine whether the medication actually works long-term.
64% of large employers say GLP-1 coverage has moderately or significantly impacted their prescription drug spending. Some have responded by dropping weight loss drug coverage entirely—which sounds like cost control but often isn’t, because untreated obesity drives spending across musculoskeletal care, cardiovascular disease, diabetes, and more.
The real problem with GLP-1 coverage isn’t the cost of the medication. It’s that most employers are covering the prescription in a silo, without the wraparound support that determines whether the investment pays off.
Sustainable weight management requires more than a prescription. Without individualized nutrition therapy, behavioral support, and clear clinical pathways, GLP-1s become a recurring cost with diminishing returns rather than a pathway to durable health improvement.
When GLP-1s are prescribed in isolation—without nutrition coaching, behavioral health support, or a clinical decision pathway that includes bariatric surgery when appropriate—members are more likely to stop the medication, regain weight, and cycle back through the benefit at full cost. Research shows that many people who stop GLP-1 medications regain up to three-quarters of the weight they lost. That’s not a failure of the drug—it’s a failure of fragmented benefit design.
The surgical gap no one is talking about
Meanwhile, bariatric surgery—one of the most clinically effective long-term interventions for obesity, with more than 90% of patients maintaining significant long-term weight loss—is often operating in its own silo on the other side of the benefits stack.
When a member needs to lose weight before a knee replacement or another musculoskeletal procedure, who is responsible for connecting them to weight management support? In most benefits structures, no one is. The orthopedic benefit and the weight management benefit don’t share data, don’t share care navigators, and don’t have a defined referral pathway between them.
The result is that employers pay for surgical procedures performed on patients who weren’t optimally prepared—which drives up complication rates, readmission rates, and long-term costs. It’s a problem that a connected weight management pathway—where a member can move from conservative care to GLP-1 therapy to surgical evaluation without starting over each time—would largely prevent it.
For a deeper look at what bariatric surgery costs employers and how those costs are trending, see our post on the growing cost of bariatric surgery and what employers can do about it.
The behavioral health blind spot
Weight management and behavioral health aren’t separate challenges—they’re deeply intertwined. Emotional eating, anxiety, depression, and disordered relationships with food are common drivers of obesity, and they’re also common consequences of major weight management interventions like bariatric surgery.
Yet in most employer benefit stacks, behavioral health is a completely separate vendor relationship with no visibility into what’s happening on the medical side.
The data on this gap is hard to ignore. 73% of employers have reported an increase in demand for mental health and substance use disorder services, and another 17% anticipate an increase. Out-of-network behavioral health spending typically runs between 25% and 30% of total behavioral health costs—and for substance use disorder, costs can climb as much as 40% out-of-network when care isn’t coordinated.
For bariatric patients specifically, the absence of behavioral health support isn’t just a quality gap—it’s a cost driver. Members who don’t receive psychological support before and after weight loss surgery face higher rates of weight regain, poorer outcomes, and more frequent re-engagement with the healthcare system. When a surgical benefit and a behavioral health benefit don’t communicate with each other, employers are left paying for both the surgery and the downstream consequences of inadequate recovery support.
What integration actually looks like—and why it matters
The alternative to fragmentation is a coordinated weight management pathway—one where GLP-1 prescribing, nutrition coaching, behavioral health support, and surgical care all exist within a single clinical framework, with defined referral pathways in both directions.
This is the model that Carrum Health and Virta Health brought to market earlier this year: a partnership that integrates Virta’s nutrition-first weight management and responsible GLP-1 prescribing with Carrum’s value-based Centers of Excellence for bariatric and surgical care. Members can move from conservative metabolic care to surgical evaluation when clinically appropriate—without starting from scratch at each transition.
The same principle applies on the behavioral health side. Carrum’s partnership with Lyra Health creates bidirectional care coordination between specialty care (including surgical and substance use disorder treatment) and comprehensive mental health services—so that a member who needs bariatric surgery also has access to behavioral health support throughout the episode, not just at the point of crisis.
What this changes for employers is significant:
Fewer dead ends. When a member’s GLP-1 therapy isn’t working, there’s a clinical pathway to the next appropriate intervention—rather than a gap where the member stops engaging entirely and the condition worsens.
Lower total cost of care. Carrum’s model has been independently validated to reduce unnecessary procedures by as much as 30%, lower readmissions by 80%, and save employers up to 45% per surgical episode. Those outcomes are only achievable when care is coordinated—not when surgical care is siloed from the weight management benefit that should have preceded it.
Simpler vendor management. Integrated care means fewer separate contracts, fewer separate care navigators, and fewer situations where a member falls through the gap between two vendors who don’t share data.
Better utilization of GLP-1s. When GLP-1 prescribing is embedded in a clinically rigorous program that includes nutrition coaching and behavioral support, members are more likely to sustain results—turning a recurring monthly prescription cost into a genuine health investment rather than a revolving door.
The employer action checklist
If you’re evaluating your current weight management benefits for fragmentation risk, here are the questions worth asking:
On GLP-1 coverage:
- Are GLP-1s being prescribed with clinical guardrails (BMI criteria, comorbidity requirements, prior authorization)?
- Is nutrition coaching and behavioral support included as part of the GLP-1 benefit—or is the medication prescribed in isolation?
- Is there a defined off-ramp for members who plateau on GLP-1s, or who would benefit more from a surgical pathway?
On bariatric benefits:
- Do members who qualify for bariatric surgery have access to pre-surgical weight management support, or are they going into the operating room without adequate preparation?
- Is there a post-surgical behavioral health pathway built into the benefit, or does that support end at discharge?
- Are you using a center of xcellence model for bariatric care, or are members accessing surgery through an open network where quality and costs vary widely? See our guide to how value-based centers of excellence work for employers.
On behavioral health coordination:
- Does your behavioral health vendor have visibility into members who are going through major weight management interventions?
- Is there a warm handoff process between your surgical benefit and your mental health benefit—particularly for bariatric and substance use disorder patients?
For a side-by-side comparison of GLP-1s and bariatric surgery to understand when each is the right clinical choice, see GLP-1 medications vs. bariatric surgery: the pros and cons of these weight loss solutions.
The bottom line
Most employers are not failing to invest in weight management. They’re investing in weight management the wrong way, through disconnected point solutions that each do one thing adequately—but none of which produce the coordinated outcomes that actually bend the cost curve.
The future of employer weight management benefits isn’t more vendors. It’s fewer, better-connected ones. It’s a system where a member can move from nutrition coaching to GLP-1 therapy to surgical care to behavioral health recovery without losing continuity, without starting over, and without falling through the gaps that drive the highest costs.
If you’re ready to evaluate what a more coordinated weight management benefit would look like for your population, Carrum Health’s savings analysis tool can give you a baseline estimate of where your current spend is going—and where a connected care model could save you money.
To learn more about how Carrum Health can help your organization build a connected weight management benefits strategy, contact us here.